Experience

Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1 Portfolio

May 17, 2024

Cooley advised Jiangsu Hengrui Pharmaceuticals, one of the largest pharmaceutical companies in China, on its licensing of global rights (excluding Greater China) for the development, production and commercialization of three of its proprietary glucagon-like peptide-1 (GLP-1) drugs to Hercules CM Newco, a newly established Delaware company.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Bill Christiansen
Partner, Seattle
Sharon Connaughton
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC
Zack Gong
Associate, Shanghai
Kevin King
Partner, Washington, DC
Edmond Lay
Associate, San Diego
Howard Morse
Partner, Washington, DC
Sarah Oliai
Associate, Washington, DC
W. Chad Shear
Partner, San Diego
Michael Shen
Counsel, Shanghai
Dr. Xixi Sun
Associate, Boston
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Ivy Wang
Associate, Shanghai
Bin Wang
Special Counsel, Palo Alto
Letian Wei
Legal Consultant, Shanghai
Dr. Heng Zhang
Patent Agent , Boston
Dr. Tian Yong Zheng
Patent Agent, Seattle
Joanna Zhang
Associate, San Diego

Related Practices & Industries

NKGen Biotech Announces Merger With Graf Acquisition Corp. IV

April 28, 2023

Cooley advised NKGen Biotech, a clinical-stage biotechnology company, on its business combination agreement with special purpose acquisition company Graf Acquisition Corp. IV – a combination that will result in NKGen becoming a publicly listed company.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Rajdeep Roger Bains
Associate, San Diego
Brett Dovman
Associate, San Diego
Dylan Kornbluth
Associate, San Diego
Arman Sagart
Associate, San Diego
Kyle Huh
Associate, Palo Alto
Madison (JJ) Meng
Associate, San Francisco
Sharon Connaughton
Special Counsel, Washington, DC
Megan Drill
Associate, San Diego
Ross Eberly
Partner, Los Angeles Santa Monica
Rick Jantz
Associate, Los Angeles Santa Monica
Christopher Kimball
Partner, Washington, DC
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles Downtown
Natasha Leskovsek
Of Counsel, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Michael Shen
Counsel, Shanghai
Jeffrey J. Tolin
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Charity Williams
Partner, San Diego

Related Practices & Industries

Luqa Ventures Sells to CMS

February 2, 2021

Cooley advised Luqa Ventures, a dermatology specialty company, on its sale of all issued and outstanding shares to China Medical System (0867.HK). Following the transaction, Luqa became a wholly-owned subsidiary of CMS. Luqa has an extensive portfolio of prescription medicines, medical devices, medical aesthetic solutions and skin care products that meets the diversified needs of consumers in China and provides the market with safe and effective solutions for a broad range of skin conditions. This acquisition marked CMS’s first foray into the medical aesthetic market. Partner James Lu led the Cooley team advising Luqa Ventures on the transaction.

Related contacts

Michael Shen
Counsel, Shanghai

Related Practices & Industries

Admissions and credentials

New York